Cidara Therapeutics Revenue and Competitors

Claim your profile



Total Funding



Estimated Revenue & Valuation

  • Cidara Therapeutics's estimated annual revenue is currently $15.5M per year.(i)
  • Cidara Therapeutics's estimated revenue per employee is $189,024
  • Cidara Therapeutics's total funding is $156.1M.

Employee Data

  • Cidara Therapeutics has 82 Employees.(i)
  • Cidara Therapeutics grew their employee count by -15% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
Add Company

Cidara Therapeutics is developing innovative therapies to treat life-threatening illnesses exacerbated by deficiencies of the human immune system. Our initial focus is on devastating fungal infections that often complicate cancer and transplant treatments. Such infections can lead to mortality rates exceeding 50%.



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Cidara Therapeutics News

2022-04-17 - Cidara Therapeutics, Inc. (NASDAQ:CDTX) Receives Average ...

Cidara Therapeutics, Inc. (NASDAQ:CDTX) Receives Average Recommendation of “Buy” from Analysts. Posted by admin on Apr 27th, 2022.

2022-04-17 - Mundipharma and Cidara Therapeutics Announce First ...

Mundipharma and Cidara Therapeutics Announce First Presentation of Results from Global Phase 3 ReSTORE Trial of Rezafungin for Treatment of...

2022-03-22 - Cidara Therapeutics Announces the Completion of Dosing the ...

Cidara is developing a new generation of immunotherapeutic antivirals from its Cloudbreak platform that couple potent antivirals to a human...

2016-11-04 - Cidara Therapeutics Receives $20M Credit Facility from Square 1 Bank

Cidara Therapeutics, Inc. (Nasdaq:CDTX), a San Diego, CA-based biotechnology company, entered into an agreement for a $20m credit facility with Square 1 Bank, a division of Pacific Western Bank. Proceeds from the facility will provide working capital to support the company’s CD101 and CD201 pro ...

2015-03-16 - Cidara Therapeutics Aims for $69M With Planned IPO

Cidara Therapeutics Inc. has filed to raise up to $69 million in an IPO, the San Diego biotech disclosed in a registration statement filed recently. The biotechnology company is developing anti-infectives and immunotherapies to treat fungal and other infections. Cidara is making a quick bet th ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding